000 | 01167 a2200313 4500 | ||
---|---|---|---|
005 | 20250515121143.0 | ||
264 | 0 | _c20080630 | |
008 | 200806s 0 0 eng d | ||
022 | _a1389-2002 | ||
024 | 7 |
_a10.2174/138920008784220619 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPatocka, Jiri | |
245 | 0 | 0 |
_aPossible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease. _h[electronic resource] |
260 |
_bCurrent drug metabolism _cMay 2008 |
||
300 |
_a332-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCholinesterase Inhibitors _xmetabolism |
650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHydroxylation |
650 | 0 | 4 |
_aNootropic Agents _xmetabolism |
650 | 0 | 4 |
_aTacrine _xanalogs & derivatives |
700 | 1 | _aJun, Daniel | |
700 | 1 | _aKuca, Kamil | |
773 | 0 |
_tCurrent drug metabolism _gvol. 9 _gno. 4 _gp. 332-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/138920008784220619 _zAvailable from publisher's website |
999 |
_c17968734 _d17968734 |